Balaam's design [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2009-09-23 14:47 (6106 d 04:00 ago) – Posting: # 4236
Views: 9,005

Dear Raveendranath!

❝ […] Balaam's design […] can we calculate Intra CV for Reference and Intra CV for Test separately?


Yes, because you have repeated administrations in the the first two sequences.

❝ If yes plz tell me the ANOVA design.


You gave the design already yourself. :confused:
I would guess that for FDA and EMEA applications you are on slippery ground (they expect 3- or 4-period replicate designs). On the other hand ANVISA states Balaam’s design in their guideline. Don’t ask me about sample size estimations – no idea…

For the evaluation see:

S-C Chow and J-p Liu
Design and Analysis of Bioavailability and Bioequivalence Studies
Marcel Dekker, New York, pp 257-266 (3rd ed. 2008)


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,571 registered users;
134 visitors (0 registered, 134 guests [including 10 identified bots]).
Forum time: 18:47 CEST (Europe/Vienna)

Outside his own ever-narrowing field of specialization,
a scientist is a layman.
What members of an academy of science have in common
is a certain form of semiparasitic living.    Erwin Chargaff

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5